Ballicules › Drugs › Sulindac
What it is COX-inhibiting NSAID prodrug converted to an active sulfide; arthritis and acute gout.
Why this one Its unusual off-label niche is suppressing colorectal polyps in familial adenomatous polyposis.
What limits it Hepatotoxicity and severe skin reactions are unusually prominent; cardiovascular and GI risks remain.
FDA-approved for
FDA label
Read the full label on DailyMed ↗
BOXED WARNING NSAID class: serious CV thrombotic events (MI, stroke), contraindicated peri-CABG; serious GI bleeding/ulceration/perforation.
FDA dosing Population Start Target Max
Osteoarthritis / rheumatoid arthritis / ankylosing spondylitis Adults 150 mg BID 150 mg BID 400 mg/day
Acute painful shoulder (subacromial bursitis/supraspinatus tendinitis) / acute gouty arthritis Adults 200 mg BID 200 mg BID 400 mg/day
Renal Undefined
Hepatic Undefined
Doses above 400 mg/day not recommended
Instructions Take with food Use lowest effective dose for shortest duration Acute painful shoulder: usually 7-14 days; acute gouty arthritis: usually 7 days
Contraindications Coronary artery bypass graft (CABG) surgery setting Aspirin/NSAID-induced asthma, urticaria, or allergic-type reactions
Cautions CV thrombotic events (MI, stroke) — use shortest duration; avoid peri-CABG GI bleeding, ulceration, perforation — can occur without warning; elderly at higher risk Hepatotoxicity; hypertension; heart failure/edema; renal effects Anaphylactic/anaphylactoid reactions; serious skin reactions
Adverse reactions GI pain Dyspepsia Nausea/vomiting Diarrhea Constipation Flatulence Rash Pruritus Dizziness Headache Edema Tinnitus
Pregnancy Avoid at ≈30 weeks gestation and later (premature ductus arteriosus closure); limit use 20-30 weeks (fetal renal dysfunction/oligohydramnios)
Lactation Undefined
⚠ BOXED WARNINGS
Cardiovascular thrombotic events Gastrointestinal bleeding, ulceration and perforation
Cost, est. cash $5–$150/month
Generic entry 1990
Classes and tags
Clinical profile
Therapeutic safety burden 2 / 4
Overdose danger 3 / 4
Weight-gain liability 0 / 4
Sedation liability 0 / 4
QT / Torsades 0 / 4
Direct muscarinic antagonism 0 / 4
Embryofetal risk 3 / 4
Legacy pregnancy category Multiple / indication-, trimester- or formulation-dependent
Defining liability GI bleeding, kidney injury, hypertension and fluid retention; many agents increase lithium concentrations.
Active metabolites
Mechanism of action: Sulindac ballicule
Open Sulindac in the interactive console ↗
Memory aids: mascots and interaction avatars
“Sully’s Clinical role” “The N said... NSAID”
Box: minimal PK interactions
Open Sulindac in the interactive console ↗